Registro:

Referencias:

• Hung, S.C., Chen, N.J., Hsieh, S.L., Li, H., Ma, H.L., Lo, W.H., Isolation and Characterization of size-sieved stem cells from human bone marrow (2002) Stem Cells, 20, pp. 249-258
• La Russa, V., Schwarzenberger, P., Miller, A., Agrawal, K., Kolls, J., Weiner, R., Marrow stem cells, mesenchymal progenitor and stromal progeny (2002) Cancer Investigation, 20, pp. 110-132
• Beresford, J.N., Osteogenic stem cells and the stromal system of bone and marrow (1989) Clin Orthop, 240, pp. 270-280
• Tocci, A., Forte, L., Mesenchymal stem cell: Use and perspectives (2003) Hematology, 4 (2), pp. 92-96
• Alhadlaq, A., Mao, J.J., Mesenchymal stem cells: Isolation and therapeutics (2004) Stem Cells Dev, 13, pp. 436-448
• Mauney, J.R., Kaplan, D.L., Volloch, V., Matrix-mediated retention of osteogenic differentiation potential by human adult bone marrow stromal cells during ex vivo expansion (2004) Biomaterials, 25, pp. 3233-3243
• Rougier, F., Dupuis, F., Denizot, Y., Human bone marrow fibroblasts an overview of their characterization, proliferation and inflammatory mediator production (1996) Hematol Cell Ther, 38, pp. 241-246
• Krebsbach, P.H., Kuznetsov, S.A., Bianco, P., Robey, P.G., Bone marrow stromal cells: Characterization and clinical application (1999) Crit Rev Oral Biol Med, 10, pp. 165-181
• Friedenstein, A.J., Latzinik, N.V., Gorskaya, Y.F., Luria, E.A., Moskvina, I.L., Bone marrow stromal colony formation requires stimulation by haemopoietic cells (1999) Bone Miner, 18, pp. 199-213
• Monje, P., Marinissen, M.J., Gutkind, J.S., Phosphorylation of the carboxyl-terminal transactivation domain of c-Fos by extracellular signal-regulated kinase mediates the transcriptional activation of AP-1 and cellular transformation induced by platelet-derived growth factor (2003) Mol Cell Biol, 23, pp. 7030-7043
• Kazlauskas, A., Di Corleto, P.E., A comparison of platelet-derived growth factor-dependent tyrosine kinase activity in sparce and confluent fibroblasts (1986) J Cell Physiol, 126, pp. 225-236
• Waters, C.M., Littlewood, T.D., Hancock, D.C., Moore, J.P., Evan, G.I., Related articles, links, c-myc protein expression in untransformed fibroblasts (1991) Oncogene, 6 (5), pp. 797-805
• Izumi, H., Molander, C., Penn, L.Z., Ishisaki, A., Kohno, K., Funa, K., Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor (2001) J Cell Sci, 114, pp. 1533-1544
• Harrington, E.A., Bennett, M.R., Fanidi, A., Evan, G.I., C-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines (1994) EMBO J, 13, pp. 3286-3295
• Okada, S., Fukuda, T., Inada, K., Tokuhisa, T., Prolonged expression of c-fos suppresses cell cycle entry of dormant hematopoietic stem cells (1999) Blood, 93, pp. 816-825
• Dang, C.V., C-Myc target genes involved in cell growth, apoptosis, and metabolism (1999) Mol Cell Biol, 19, pp. 1-11
• Chasseing, N.A., Trejo, Y.G., Bordenave, R.H., Bullorsky, E.O., Diaz, N.B., Rumi, L.S., Bone marrow fibroblastic progenitors in patients with advanced breast cancer (1997) Breast Cancer Res Treat, 45, pp. 211-218
• Chasseing, N.A., Bordenave, R.H., Bullorsky, E.O., Diaz, N.B., Stemmelin, G.R., Rumi, L.S., Fibroblastic colony forming units and levels of tumor necrosis factor alpha and prostaglandin E2 in bone marrow cultures from patients with advanced lung cancer (1997) Cancer, 80, pp. 1914-1919
• Honegger, A., Hofer, E.L., Baranao, R.I., Mackinlay, T.A., Mackinlay, D.A., Bullorsky, E.O., Bordenave, R.H., Chasseing, N.A., Interleukin-1 beta, transforming growth factor beta-1, prostaglandin E2 and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast cancer patients (2002) Ann Hematol, 81, pp. 80-85
• Chasseing, N., Honegger, A., Bordenave, R., Hofer, E., Shandley, C., Rumi, L., Effect of conditioned medium of bone marrow fibroblast colony forming units (CFU-F) from patients with solid tumor on the growth of normal CFU-F (1999) Eur J Cancer, 35, p. 383
• Hofer, E., Honegger, A., Bullorsky, E., Martinez, J., Chasseing, N., Production of stimulating and inhibiting factors of bone marrow fibroblast colonies in untreated lung and breast cancer patients (2001) Haematol J, 1, p. 253
• Castro-Malaspina, H., Gay, R.E., Resnick, G., Kapoor, N., Meyers, P., Chiarieri, D., McKenzie, S., Moore, M.A.S., Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny (1980) Blood, 56, pp. 289-301
• Paulsson, Y., Bywater, M., Heldin, C.H., Westermark, B., Effects of epidermal growth factor and platelet-derived growth factor on c-fos and c-myc mRNA levels in normal human fibroblasts (1987) Exp Cell Res, 171, pp. 186-194
• Dooley, D.C., Oppenlander, B.K., Spurgin, P., Mead, J.H., Novak, F.P., Plunkett, M., Beckstead, J., Heinrich, M.C., Basic fibroblasts growth factor and epidermal growth factor downmodulate the growth of hematopoietic cells in long-term stromal cultures (1995) J Cell Physiol, 165, pp. 386-397
• Yoon, S.Y., Tefferi, A., Li, C.Y., Cellular distribution of platelet-derived growth factor, transforming growth factor-β, basic fibroblasts growth factor and their receptors in normal bone marrow (2000) Acta Hematolog, 104, pp. 151-157
• Barry, F.P., Boynton, R.E., Haynesworth, S., Murphy, J.M., Zaia, J., The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD 105) (1999) Biochem Biophys Res Commun, 265, pp. 134-139
• Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bernabeu, C., Massague, J., Letarte, M., Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells (1992) J Biol Chem, 267, pp. 19027-19030
• Claassen, G.F., Hann, S.R., A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest (2000) Proc Natl Acad Sci USA, 97, pp. 9498-9503
• Beresford, J.N., Osteogenic stem cells and the stromal system of bone and marrow (1989) Clin Orthop, 240, pp. 270-280
• Bonyadi, M., Waldman, S.D., Liu, D., Aubin, J.E., Grynpas, M.D., Stanford, W.L., Mesenchymal progenitor of self-renewal deficiency leads to age-dependent osteoporosis in Sea-1/Ly-6A null mice (2003) Proc Natl Acad Sci USA, 100, pp. 5840-5845
• Hofer, E.L., Caramutti, D., La Russa, V., Feldman, L., Bordenave, R.H., Chasseing, N.A., Osteogenic potential of bone marrow mesenchymal cells from chemonaive advanced breast cancer patients, as prognostic factor in bone diseases (2004) Cytotherapy, , abstract 27 (in press)
• Compston, J.E., Bone marrow and bone: A functional unit (2002) J Endocrinol, 173, pp. 387-394

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------